Percussionaire IPV Therapy In-Line Valve Recalled for Labeling Deficiency
Percussionaire Corporation recalled 2523 IPV therapy in-line valves due to insufficient labeling regarding cap removal prior to use. Updated labeling ensures patients and healthcare providers understand proper device preparation.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This recall is classified FDA Class I, which requires a minimum severity score of 4 per FDA guidelines for serious health hazards. While no illnesses or injuries have been reported, the labeling deficiency poses a risk to proper device function and patient therapy delivery.
Plain-English summary
Percussionaire Corporation has recalled 2523 units of its IPV (Intrapulmonary Percussive Ventilation) therapy in-line valve (REF: P5-TEE-20) due to a labeling deficiency. The FDA classified this as a Class I recall, indicating a serious potential health hazard.
The in-line valve includes a blue cap that must be removed prior to delivery and use of the device for IPV therapy. The original labeling did not adequately ensure this critical preparation step was communicated. Percussionaire Corporation has updated the labeling to clearly require removal of the blue cap before the device is delivered to or used by patients.
The recalled units were distributed nationwide in the United States and internationally to Israel, Japan, Russia, Switzerland, Canada, and Turkey. Affected units span multiple production lots and work orders.
Patients, healthcare facilities, and respiratory therapy providers who have received these devices should verify that the blue cap has been removed from the in-line valve before use. If you have received affected units, contact Percussionaire Corporation for guidance.
The recalled product
- Product
- Percussionaire, Inc., REF: P5-TEE-20, Qty: 20, Rx Only. IPV (Intrapulmonary Percussive Ventilation) therapy In-Line Valve
- Manufacturer
- Percussionaire Corporation
- Affected units
- 2,523
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 2 recalled by Percussionaire Corporation under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same manufacturer · Percussionaire Corporation
See all →- CriticalPercussive ventilation valves recalled over leak risk in small patients
FDA (Devices) · 2025-10-22
- SevereVDR4 Phasitron Breathing Circuit Recalled for Potential Ventilation Reduction
FDA (Devices) · 2025-01-29
- SeverePhasitron5 breathing circuits recalled for nickel-coated spring discoloration
FDA (Devices) · 2024-11-06
- SeverePercussionaire IPV In-Line Valve Recall: Blue Cap Removal Labeling Update
FDA (Devices) · 2024-10-09
- SevereBreathing Circuit Kits Recalled Due to Assembly Error Affecting Pressure
FDA (Devices) · 2024-01-24
Same hazard · improper assembly
See all →- HighUnited Orthopedic Corp. Recalls Femoral Valgus Offset Adaptors for U2 Total Knee System
FDA (Devices) · 2026-08-12
- SevereAudi e-tron brake pedal may detach from the brake booster
NHTSA · 2026-04-15
- High
- SevereCOVID-19 nasopharyngeal sample collection tray recalled due to improper assembly
FDA (Devices) · 2022-07-13
- High